A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor
A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor
Recruiting · NCT06365840 · Registry updated 2026-04-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor | Histologically or Cytologically Proven Metastatic or Locally Advanced Solid Tumors; TMB-H | Recruiting | Phase 2 | 2026-04-17 | NCT06365840 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ImmuneOncia Therapeutics Inc. | 3 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Cancer Center | Goyang | South Korea | 14 |
| Samsung Medical Center | Seoul | South Korea | 170 |
| Seoul National University Bundang Hospital | Seongnam | South Korea | 42 |
| Severance Hospital | Seoul | South Korea | 62 |